Novel transplant strategies for generating graft-versus-leukemia effect in acute myeloid leukemia (Q37829878)

24 August 2017

1 reference

title

Novel transplant strategies for generating graft-versus-leukemia effect in acute myeloid leukemia (English)

1 reference

Marcelo A. Fernández-Viña

24 August 2017

1 reference

series ordinal

object named as

Marcelo Fernandez-Vina

1 reference

24 August 2017

Simrit Parmar

1 reference

24 August 2017

Marcos de Lima

series ordinal

1 reference

24 August 2017

Marcelo Fernandez-Vina

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21245756

22 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21245756

22 November 2024

publication date

1 March 2011

1 reference

24 August 2017

March 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21245756

full work available at URL

22 November 2024

https://journals.lww.com/10.1097/MOH.0b013e328343b858

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Current Opinion in Hematology

22 November 2024

published in

1 reference

24 August 2017

1 reference

24 August 2017

1 reference

24 August 2017

page(s)

98-104

1 reference

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

In search of the 'missing self': MHC molecules and NK cell recognition

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

MHC class I molecules and KIRs in human history, health and survival

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Rapid natural killer cell recovery determines outcome after T-cell-depleted HLA-identical stem cell transplantation in patients with myeloid leukemias but not with acute lymphoblastic leukemia

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Donor KIR Genes 2DL5A, 2DS1 and 3DS1 are associated with a reduced rate of leukemia relapse after HLA-identical sibling stem cell transplantation for acute myeloid leukemia but not other hematologic malignancies

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Donor leukocyte infusions for the treatment of relapsed acute leukemia after allogeneic stem cell transplantation

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Donor lymphocyte infusion for leukemia relapse after hematopoietic stem cell transplantation

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Reduced intensity conditioning and prophylactic DLI can cure patients with high-risk acute leukaemias if complete donor chimerism can be achieved

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplan

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions.

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Adoptive cell transfer: a clinical path to effective cancer immunotherapy

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

A novel minor histocompatibility antigen recognized by HLA-A31 restricted cytotoxic T lymphocytes generated from HLA-identical bone marrow donor lymphocytes

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Generation of helper and cytotoxic CD4+T cell clones specific for the minor histocompatibility antigen H-Y, after in vitro priming of human T cells by HLA-identical monocyte-derived dendritic cells

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Acute myeloid leukemia: epidemiology and etiology

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Minor histocompatibility antigens as targets of graft-versus-leukemia reactions

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

PR1 vaccination in myeloid malignancies

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

22 November 2024

Immunotherapy of AML.

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Immunotherapy of acute myeloid leukemia: current approaches.

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Myeloid leukemic progenitor cells can be specifically targeted by minor histocompatibility antigen LRH-1-reactive cytotoxic T cells

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Calcineurin inhibitor-free GVHD prophylaxis with sirolimus, mycophenolate mofetil and ATG in Allo-SCT for leukemia patients with high relapse risk: an observational cohort study

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Flt3 ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1alpha(CXCL12)/CXCR4 axis.

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemia

22 November 2024

1 reference

https://api.crossref.org/works/10.1097/MOH.0B013E328343B858

22 November 2024

Identifiers

DOI

1 reference

release_j3q33u4w2zee5lqgmlxo5yxr3m

24 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j3q33u4w2zee5lqgmlxo5yxr3m

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference